SCHEMBL12712433

SCHEMBL12712433

Cc1cc(/C=C2\SC(=O)N(Cc3ccccc3C(F)(F)F)C2=O)ccc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 2/20 0.56
▸ PIM1 P11309 1/20 0.51
▸ S1PR1 P21453 3/20 0.49
▸ BAG3 O95817 1/20 0.48
▸ CFTR P13569 1/20 0.46
▸ PPARG P37231 2/20 0.46
▸ S1PR3 Q99500 2/20 0.46
▸ NLRP3 Q96P20 1/20 0.46
▸ ESRRA P11474 1/20 0.46
▸ PTPN1 P18031 1/20 0.45
▸ ACP1 P24666 1/20 0.45
▸ ENPP2 Q13822 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ CRHBP P24387 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ CRHR2 Q13324 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614720 0.91 SLC2A1 (0.65) SLC2A1PIM1S1PR1BAG3CFTR
SCHEMBL12712452 0.89 PIM1 (0.50) SLC2A1PIM1S1PR1BAG3CFTR
SCHEMBL1614943 0.84 PIM1 (0.53) SLC2A1PIM1CFTRPPARGNLRP3
SCHEMBL12712437 0.82 ENPP2 (0.64) S1PR1PPARGS1PR3PTPN1ACP1
SCHEMBL2174424 0.80 SLC2A1 (0.60) SLC2A1PIM1S1PR1PPARGNLRP3
SCHEMBL2174422 0.80 SLC2A1 (0.60) SLC2A1PIM1S1PR1PPARGNLRP3
SCHEMBL12406528 0.80 SLC2A1 (0.60) SLC2A1PIM1S1PR1PPARGNLRP3
SCHEMBL1613781 0.80 PIM1 (0.53) SLC2A1PIM1PPARGNLRP3ESRRA
SCHEMBL2171659 0.79 SLC2A1 (0.66) SLC2A1PIM1PPARGNLRP3PTPN1
SCHEMBL1614982 0.79 SLC2A1 (0.66) SLC2A1PIM1PPARGNLRP3PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS PCK2, AK2, SIRT6 SLC2A1 76/4885PIM1 2193/4885S1PR1 1162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback